Daily BriefsSingapore

Daily Brief Singapore: Great Eastern Holdings, Grab Holdings , OUE Ltd, Scilex Holding and more

In today’s briefing:

  • Great Eastern (GE SP): Getting Technical
  • Grab Holdings (GRAB US) – Rich in Initiatives
  • 10 in 10 with OUE Healthcare – Sustainable Expansion across Asia
  • SCLX: Making Decisions That Should Boost Revenue


Great Eastern (GE SP): Getting Technical

By David Blennerhassett

  • Great Eastern Holdings (GE SP) has consistently traded through OCBC (OCBC SP)‘s Offer terms from the onset. 
  • OCBC did not declare its S$25.60 cash Offer final. And someone appears to be accumulating a stake to block an Exit/Delisting Offer, presumably towards negotiating a bump in terms.
  • But what happens if GE’s free float falls <10% at the close of the Offer and GE is suspended? And OCBC has no intention of restoring the float?

Grab Holdings (GRAB US) – Rich in Initiatives

By Angus Mackintosh

  • Grab‘s focus last year was offering more affordable products, which helped to increase its addressable market. FY2024 will see the rollout of a broader range of initiatives across economic segments. 
  • This year Grab is rolling out more premium offerings and new initiatives, including advance bookings, family accounts, increased reviews, and new merchant features to grow revenue streams from advertising.
  • The upcoming results are likely to reflect seasonal factors but should also reveal something about Grab’s new initiatives and the changing competitive environment, with GoTo investing more aggressively. 

10 in 10 with OUE Healthcare – Sustainable Expansion across Asia

By Geoff Howie

10 in 10 with OUE Healthcare – Sustainable Expansion across Asia

SCLX: Making Decisions That Should Boost Revenue

By Zacks Small Cap Research

  • SCLX is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products.
  • The company already has commercialized products that are proven to improve patients’ lives.
  • The company reported 1Q2024 results that were a little shy of estimates, but growth continues, and the product line should accelerate growth in the coming years.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars